目次

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Regenerative Medicine Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Increasing Strategic Activities and Collaborations
3.2.1.2 Rise in Research and Development Projects
3.2.1.3 Surging Government Support
3.2.2 Market Restraining Factors
3.2.2.1 Substantial Number of Product Recalls
3.2.2.2 Unapproved Products in the Market
3.2.3 Market Opportunities
3.2.3.1 Growing Research Partnership in Developed and Developing Countries across the globe
3.2.3.2 Growing awareness about the advances in medical research
3.2.3.3 Growing Investment and Funding
3.2.4 .COVID-19 Impact Analysis
3.3 Porter’s Five Forces Analysis
3.3.1 Bargaining Power of Suppliers
3.3.2 Bargaining Power of Buyers
3.3.3 Competitive Rivalry
3.3.4 Threat from Substitutes
3.3.5 Threat of New Entrants
3.4 PEST Analysis

4 Regenerative Medicine Market Analysis by Product
4.1 Key Findings
4.2 Product Segment: Market Attractiveness Index
4.3 Regenerative Medicine Market Size Estimation and Forecast by Product
4.4 Stem Cell Therapy
4.4.1 Regenerative Medicine Market Forecast by Stem Cell Therapy, 2023-2033 (US$ Bn)
4.4.1.1 Market Size by Region, 2023-2033 (US$ Bn)
4.4.1.2 Market Share by Region, 2023 & 2033 (%)
4.5 Tissue Engineering
4.5.1.1 Regenerative Medicine Market Forecast by Tissue Engineering, 2023-2033 (US$ Bn)
4.5.1.2 Market Size by Region, 2023-2033 (US$ Bn)
4.5.1.3 Market Share by Region, 2023 & 2033 (%)
4.6 Gene Therapy
4.6.1.1 Market Size by Region, 2023-2033 (US$ Bn)
4.6.1.2 Market Share by Region, 2023 & 2033 (%)
4.7 Others
4.7.1.1 Market Size by Region, 2023-2033 (US$ Bn)
4.7.1.2 Market Share by Region, 2023 & 2033 (%)

5 Regenerative Medicine Market Analysis by Application
5.1 Key Findings
5.2 Product Segment: Market Attractiveness Index
5.3 Regenerative Medicine Market Size Estimation and Forecast by Application
5.4 Oncology
5.4.1 Market Size by Region, 2023-2033 (US$ Bn)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Dermatology
5.5.1 Market Size by Region, 2023-2033 (US$ Bn)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Musculoskeletal
5.6.1 Market Size by Region, 2023-2033 (US$ Bn)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Neurology
5.7.1 Market Size by Region, 2023-2033 (US$ Bn)
5.7.2 Market Share by Region, 2023 & 2033 (%)
5.8 Cardiovascular
5.8.1 Market Size by Region, 2023-2033 (US$ Bn)
5.8.2 Market Share by Region, 2023 & 2033 (%)
5.9 Wound Healing
5.9.1 Market Size by Region, 2023-2033 (US$ Bn)
5.9.2 Market Share by Region, 2023 & 2033 (%)
5.10 Ophthalmology
5.10.1 Market Size by Region, 2023-2033 (US$ Bn)
5.10.2 Market Share by Region, 2023 & 2033 (%)
5.11 Others
5.11.1 Market Size by Region, 2023-2033 (US$ Bn)
5.11.2 Market Share by Region, 2023 & 2033 (%)

6 Regenerative Medicine Market Analysis by Region
6.1 Key Findings
6.2 Regional Segment: Market Attractiveness Index
6.3 Regenerative Medicine Market Size Estimation and Forecast

7 North America Regenerative Medicine Market Analysis
7.1 Key Findings
7.2 North America Regenerative Medicine Market Attractiveness Index
7.3 North America Regenerative Medicine Market by Country, 2023, 2028 & 2033 (US$ Bn)
7.4 North America Regenerative Medicine Market Size Estimation and Forecast by Country
7.5 North America Regenerative Medicine Market Size Estimation and Forecast by Product
7.6 North America Regenerative Medicine Market Size Estimation and Forecast by Application
7.7 U.S. Regenerative Medicine Market Analysis
7.8 Canada Regenerative Medicine Market Analysis

8 Europe Regenerative Medicine Market Analysis
8.1 Key Findings
8.2 Europe Regenerative Medicine Market Attractiveness Index
8.3 Europe Regenerative Medicine Market by Country, 2023, 2028 & 2033 (US$ Bn)
8.4 Europe Regenerative Medicine Market Size Estimation and Forecast by Country
8.5 Europe Regenerative Medicine Market Size Estimation and Forecast by Product
8.6 Europe Regenerative Medicine Market Size Estimation and Forecast by Application
8.7 Germany Regenerative Medicine Market Analysis
8.8 France Regenerative Medicine Market Analysis
8.9 UK Regenerative Medicine Market Analysis
8.10 Italy Regenerative Medicine Market Analysis
8.11 Spain Regenerative Medicine Market Analysis
8.12 Russia Regenerative Medicine Market Analysis
8.13 Rest of Europe Regenerative Medicine Market Analysis

9 Asia Pacific Regenerative Medicine Market Analysis
9.1 Key Findings
9.2 Asia Pacific Regenerative Medicine Market Attractiveness Index
9.3 Asia Pacific Regenerative Medicine Market by Country, 2023, 2028 & 2033 (US$ Bn)
9.4 Asia Pacific Regenerative Medicine Market Size Estimation and Forecast by Country
9.5 Asia Pacific Regenerative Medicine Market Size Estimation and Forecast by Product
9.6 Asia Pacific Regenerative Medicine Market Size Estimation and Forecast by Application
9.7 Japan Regenerative Medicine Market Analysis
9.8 China Regenerative Medicine Market Analysis
9.9 India Regenerative Medicine Market Analysis
9.10 Australia Regenerative Medicine Market Analysis
9.11 South Korea Regenerative Medicine Market Analysis
9.12 Rest of Asia Pacific Regenerative Medicine Market Analysis

10 Latin America Regenerative Medicine Market Analysis
10.1 Key Findings
10.2 Latin America Regenerative Medicine Market Attractiveness Index
10.3 Latin America Regenerative Medicine Market by Country, 2023, 2028 & 2033 (US$ Bn)
10.4 Latin America Regenerative Medicine Market Size Estimation and Forecast by Country
10.5 Latin America Regenerative Medicine Market Size Estimation and Forecast by Product
10.6 Latin America Regenerative Medicine Market Size Estimation and Forecast by Application
10.7 Brazil Regenerative Medicine Market Analysis
10.8 Mexico Regenerative Medicine Market Analysis
10.9 Rest of Latin America Regenerative Medicine Market Analysis

11 MEA Regenerative Medicine Market Analysis
11.1 Key Findings
11.2 MEA Regenerative Medicine Market Attractiveness Index
11.3 MEA Regenerative Medicine Market by Country, 2023, 2028 & 2033 (US$ Bn)
11.4 MEA Regenerative Medicine Market Size Estimation and Forecast by Country
11.5 MEA Regenerative Medicine Market Size Estimation and Forecast by Product
11.6 MEA Regenerative Medicine Market Size Estimation and Forecast by Application
11.7 GCC Regenerative Medicine Market Analysis
11.8 South Africa Regenerative Medicine Market Analysis
11.9 Rest of MEA Regenerative Medicine Market Analysis

12 Company Profiles
12.1 Company share analysis, 2021
12.2 Amgen
12.2.1 Company Snapshot
12.2.2 Company Overview
12.2.3 Financial Analysis
12.2.3.1 Net Revenue, 2017-2021
12.2.3.2 R&D, 2017-2021
12.2.3.3 Regional Market Shares, 2021
12.2.4 Product Benchmarking
12.2.5 Strategic Outlook
12.3 Anterogen
12.3.1 Company Snapshot
12.3.2 Company Overview
12.3.3 Financial Analysis
12.3.3.1 Net Revenue, 2017-2021
12.3.3.2 R&D, 2017-2021
12.3.4 Product Benchmarking
12.4 Avita Medical, Inc.
12.4.1 Company Snapshot
12.4.2 Company Overview
12.4.3 Financial Analysis
12.4.3.1 Net Revenue, 2017-2021
12.4.3.2 R&D, 2017-2021
12.4.3.3 Regional Market Shares, 2021
12.4.4 Product Benchmarking
12.4.5 Strategic Outlook
12.5 Bio Solution Co. Ltd.
12.5.1 Company Snapshot
12.5.2 Company Overview
12.5.3 Financial Analysis
12.5.3.1 Net Revenue, 2017-2021
12.5.4 Product Benchmarking
12.5.5 Strategic Outlook
12.6 Bluebird Bio, Inc.
12.6.1 Company Snapshot
12.6.2 Company Overview
12.6.3 Financial Analysis
12.6.3.1 Net Revenue, 2017-2021
12.6.3.2 R&D, 2017-2021
12.6.4 Product Benchmarking
12.6.5 Strategic Outlook
12.7 Bristol Myers Squibb
12.7.1 Company Snapshot
12.7.2 Company Overview
12.7.3 Financial Analysis
12.7.3.1 Net Revenue, 2017-2022
12.7.3.2 R&D, 2017-2022
12.7.3.3 Regional Market Shares, 2022
12.7.4 Product Benchmarking
12.7.5 Strategic Outlook
12.8 Gilead Sciences, Inc.
12.8.1 Company Snapshot
12.8.2 Company Overview
12.8.3 Financial Analysis
12.8.3.1 Net Revenue, 2017-2022
12.8.3.2 R&D, 2017-2021
12.8.3.3 Regional Market Shares, 2022
12.8.4 Product Benchmarking
12.8.5 Strategic Outlook
12.9 Integra LifeSciences
12.9.1 Company Snapshot
12.9.2 Company Overview
12.9.3 Financial Analysis
12.9.3.1 Net Revenue, 2017-2021
12.9.3.2 R&D, 2017-2021
12.9.3.3 Regional Market Shares, 2021
12.9.4 Product Benchmarking
12.9.5 Strategic Outlook
12.10 Mesoblast Ltd
12.10.1 Company Snapshot
12.10.2 Company Overview
12.10.3 Financial Analysis
12.10.3.1 Net Revenue, 2017-2022
12.10.3.2 R&D, 2017-2021
12.10.4 Product Benchmarking
12.10.5 Strategic Outlook
12.11 Novartis AG
12.11.1 Company Snapshot
12.11.2 Company Overview
12.11.3 Financial Analysis
12.11.3.1 Net Revenue, 2017-2022
12.11.3.2 R&D, 2017-2022
12.11.3.3 Regional Market Shares, 2022
12.11.4 Product Benchmarking
12.11.5 Strategic Outlook
12.12 Organogenesis Inc.
12.12.1 Company Snapshot
12.12.2 Company Overview
12.12.3 Financial Analysis
12.12.3.1 Net Revenue, 2017-2021
12.12.3.2 R&D, 2017-2021
12.12.4 Product Benchmarking
12.12.5 Strategic Outlook
12.13 Sarepta Therapeutics, Inc.
12.13.1 Company Snapshot
12.13.2 Company Overview
12.13.3 Financial Analysis
12.13.3.1 Net Revenue, 2017-2021
12.13.3.2 R&D, 2017-2021
12.13.4 Product Benchmarking
12.13.5 Strategic Outlook
12.14 Sibiono GeneTech Co. Ltd
12.14.1 Company Snapshot
12.14.2 Company Overview
12.14.3 Product Benchmarking
12.15 Smith & Nephew plc
12.15.1 Company Snapshot
12.15.2 Company Overview
12.15.3 Financial Analysis
12.15.3.1 Net Revenue, 2017-2021
12.15.3.2 R&D, 2017-2021
12.15.3.3 Regional Market Shares, 2021
12.15.4 Product Benchmarking
12.15.5 Strategic Outlook
12.16 Terumo BCT
12.16.1 Company Snapshot
12.16.2 Company Overview
12.16.3 Financial Analysis
12.16.3.1 Net Revenue, 2017-2021
12.16.3.2 R&D, 2017-2021
12.16.3.3 Regional Market Shares, 2021
12.16.4 Product Benchmarking
12.16.5 Strategic Outlook

13 Conclusion and Recommendations
13.1 Concluding Remarks from Visiongain
13.2 Recommendations for Market Players

List of Tables
Table 1 Regenerative Medicine Market Snapshot, 2023 & 2033 (US$ billion, CAGR %)
Table 2 Regenerative Medicine Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR (%)): “V” Shaped Recovery Scenario
Table 3 Regenerative Medicine Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR (%)): “U” Shaped Recovery Scenario
Table 4 Regenerative Medicine Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR (%)): “W” Shaped Recovery Scenario
Table 5 Regenerative Medicine Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR (%)): “L” Shaped Recovery Scenario
Table 6 Regenerative Medicine Market Forecast by Product, 2023-2033 (US$ bn, AGR (%), CAGR (%))
Table 7 Regenerative Medicine Market Forecast by Stem Cell Therapy, 2023-2033 (US$ bn, AGR (%), CAGR (%))
Table 8 Stem Cell Therapy Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 9 Regenerative Medicine Market Forecast by Tissue Engineering, 2023-2033 (US$ bn, AGR (%), CAGR (%))
Table 10 Tissue Engineering Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 11 Gene Therapy Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 12 Others Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 13 Regenerative Medicine Market Forecast by Application, 2023-2033 (US$ bn, AGR (%), CAGR (%))
Table 14 Oncology Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 15 Dermatology Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 16 Musculoskeletal Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 17 Neurology Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 18 Cardiovascular Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 19 Wound Healing Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 20 Ophthalmology Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 21 Others Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 22 Regenerative Medicine Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR (%))
Table 23 North America Regenerative Medicine Market Forecast by Country 2023-2033 (US$ bn, AGR%, CAGR %)
Table 24 Regenerative Medicine Market Forecast by Product, 2023-2033 (US$ bn, AGR (%), CAGR (%))
Table 25 Regenerative Medicine Market Forecast by Application, 2023-2033 (US$ bn, AGR (%), CAGR (%))
Table 26 U.S. Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR %, CAGR %)
Table 27 Canada Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR %, CAGR %)
Table 28 Europe Regenerative Medicine Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 29 Regenerative Medicine Market Forecast by Product, 2023-2033 (US$ bn, AGR (%), CAGR (%))
Table 30 Regenerative Medicine Market Forecast by Application, 2023-2033 (US$ bn, AGR (%), CAGR (%))
Table 31 Germany Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 32 France Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 33 UK Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 34 Italy Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 35 Spain Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 36 Russia Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 37 Rest of Europe Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 38 Asia Pacific Regenerative Medicine Market forecast by Country 2023-2033 (US$ bn, AGR%, CAGR %)
Table 39 Regenerative Medicine Market Forecast by Product, 2023-2033 (US$ bn, AGR (%), CAGR (%))
Table 40 Regenerative Medicine Market Forecast by Application, 2023-2033 (US$ bn, AGR (%), CAGR (%))
Table 41 Japan Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Table 42 China Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 43 India Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 44 Australia Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 45 South Korea Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Table 46 Rest of Asia Pacific Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 47 Latin America Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 48 Regenerative Medicine Market Forecast by Product, 2023-2033 (US$ bn, AGR (%), CAGR (%))
Table 49 Regenerative Medicine Market Forecast by Application, 2023-2033 (US$ bn, AGR (%), CAGR (%))
Table 50 Brazil Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 51 Mexico Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 52 Rest of Latin America Regenerative Drugs Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 53 MEA Regenerative Drugs forecast by Country 2023-2033 (US$ bn, AGR%, CAGR %)
Table 54 Regenerative Medicine Market Forecast by Product, 2023-2033 (US$ Bn, AGR (%), CAGR (%))
Table 55 Regenerative Medicine Market Forecast by Application, 2023-2033 (US$ Bn, AGR (%), CAGR (%))
Table 56 GCC Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 57 South Africa Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 58 Rest of MEA Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 59 Amgen : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 60 Amgen : Product Benchmarking
Table 61 Amgen : Strategic Outlook
Table 62 Anterogen : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 63 Anterogen : Product Benchmarking
Table 64 Avita Medical, Inc. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 65 Avita Medical , Inc. : Product Benchmarking
Table 66 Avita Medical , Inc. : Strategic Outlook
Table 67 Bio Solution Co. Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 68 Bio Solution Co. Ltd .: Product Benchmarking
Table 69 Bio Solution Co. Ltd .: Strategic Outlook
Table 70 Bluebird Bio, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 71 Bluebird Bio, Inc.: Product Benchmarking
Table 72 Bluebird Bio, Inc.: Strategic Outlook
Table 73 Bristol Myers Squibb : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 74 Bristol Myers Squibb : Product Benchmarking
Table 75 Bristol Myers Squibb : Strategic Outlook
Table 76 Gilead Sciences, Inc. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 Gilead Sciences, Inc. : Product Benchmarking
Table 78 Gilead Science, Inc. : Strategic Outlook
Table 79 Integra LifeSciences :(CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 80 Integra LifeSciences : Product Benchmarking
Table 81 Integra LifeSciences .: Strategic Outlook
Table 82 Mesoblast Ltd : (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 Mesoblast Ltd : Product Benchmarking
Table 84 Mesoblast Ltd .: Strategic Outlook
Table 85 Novartis AG ,: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 Novartis AG: : Product Benchmarking
Table 87 Novartis AG: .: Strategic Outlook
Table 88 Organogenesis Inc. :(CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Organogenesis Inc. : Product Benchmarking
Table 90 Organogenesis Inc.: Strategic Outlook
Table 91 Sarepta Therapeutics, Inc. :(CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Sarepta Therapeutics, Inc.: Product Benchmarking
Table 93 Sarepta Therapeutics, Inc..: Strategic Outlook
Table 94 Sibiono GeneTech Co. Ltd :(CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Sibiono GeneTech Co. Ltd : Product Benchmarking
Table 96 Smith & Nephew plc,: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 Smith & Nephew: : Product Benchmarking
Table 98 Smith & Nephew: .: Strategic Outlook
Table 99 Terumo BCT,: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 100 Terumo BCT: : Product Benchmarking
Table 101 Terumo BCT: .: Strategic Outlook
?

List of Figures
Figure 1 Regenerative Medicine Market Segmentation
Figure 2 Regenerative Medicine Market by Product: Market Attractiveness Index
Figure 3 Regenerative Medicine Market Attractiveness Index by Application
Figure 4 Regenerative Medicine Market Attractiveness Index by Region
Figure 5 Regenerative Medicine Market: Market Dynamics
Figure 6 COVID Impact Analysis: Regenerative Medicine Market Recovery Scenarios
Figure 7 Regenerative Medicine Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 8 Regenerative Medicine Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 9 Regenerative Medicine Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 10 Regenerative Medicine Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 11 Regenerative Medicine Market: Porter’s Five Forces Analysis
Figure 12 Regenerative Medicine Market: PEST Analysis
Figure 13 Regenerative Medicine Market by Product: Market Attractiveness Index
Figure 14 Regenerative Medicine Market Forecast by Product , 2023-2033 (US$ billion)
Figure 15 Regenerative Medicine Market Share Forecast by Product, 2023-2033 (%)
Figure 16 Stem Cell Therapy Market Forecast by Region, 2023-2033 (US$ billion)
Figure 17 Stem Cell Therapy Market Share Forecast by Region, 2023 & 2033 (%)
Figure 18 Tissue Engineering Market Forecast by Region, 2023-2033 (US$ billion)
Figure 19 Tissue Engineering Market Share Forecast by Region, 2023 & 2033 (%)
Figure 20 Gene Therapy Market Forecast by Region, 2023-2033 (US$ billion)
Figure 21 Gene Therapy Market Share Forecast by Region, 2023 & 2033 (%)
Figure 22 Others Market Forecast by Region, 2023-2033 (US$ billion)
Figure 23 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 24 Regenerative Medicine Market by Application: Market Attractiveness Index
Figure 25 Regenerative Medicine Market Forecast by Application , 2023-2033 (US$ billion)
Figure 26 Regenerative Medicine Market Share Forecast by Application, 2023-2033 (%)
Figure 27 Oncology Market Forecast by Region, 2023-2033 (US$ billion)
Figure 28 Oncology Market Share Forecast by Region, 2023 & 2033 (%)
Figure 29 Dermatology Market Forecast by Region, 2023-2033 (US$ billion)
Figure 30 Dermatology Market Share Forecast by Region, 2023 & 2033 (%)
Figure 31 Musculoskeletal Market Forecast by Region, 2023-2033 (US$ billion)
Figure 32 Musculoskeletal Market Share Forecast by Region, 2023 & 2033 (%)
Figure 33 Neurology Market Forecast by Region, 2023-2033 (US$ billion)
Figure 34 Neurology Market Share Forecast by Region, 2023 & 2033 (%)
Figure 1 Cardiovascular Market Forecast by Region, 2023-2033 (US$ billion)
Figure 2 Cardiovascular Market Share Forecast by Region, 2023 & 2033 (%)
Figure 3 Wound Healing Market Forecast by Region, 2023-2033 (US$ billion)
Figure 4 Wound Healing Market Share Forecast by Region, 2023 & 2033 (%)
Figure 5 Ophthalmology Market Forecast by Region, 2023-2033 (US$ billion)
Figure 6 Ophthalmology Market Share Forecast by Region, 2023 & 2033 (%)
Figure 7 Others Market Forecast by Region, 2023-2033 (US$ billion)
Figure 8 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 9 Regenerative Medicine Market by Region: Market Attractiveness Index
Figure 10 Regenerative Medicine Market by Region, 2023-2033 (US$ bn)
Figure 11 Regenerative Medicine Market Share Forecast by Region 2023, 2033(%)
Figure 12 North America Regenerative Medicine Market Attractiveness Index
Figure 13 North America Regenerative Medicine Market by Region, 2023, 2028 & 2033 (US$ billion)
Figure 14 North America Regenerative Medicine Market Forecast by Country, 2023-2033 (US$ billion)
Figure 15 North America Regenerative Medicine Market Share Forecast by Country, 2023 & 2033 (%)
Figure 16 North America Regenerative Medicine Market Forecast by Product, 2023-2033 (US$ billion)
Figure 17 North America Regenerative Medicine Market Share Forecast by Product, 2023 & 2033 (%)
Figure 18 North America Regenerative Medicine Market Forecast by Application, 2023-2033 (US$ billion)
Figure 19 North America Regenerative Medicine Market Share Forecast by Application, 2023 & 2033 (%)
Figure 20 U.S. Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 21 Canada Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 22 Europe Regenerative Medicine Market Attractiveness Index
Figure 23 Europe Regenerative Medicine Market by Region, 2023, 2028 & 2033 (US$ billion)
Figure 24 Europe Regenerative Medicine Market Forecast by Country, 2023-2033 (US$ billion)
Figure 25 Europe Regenerative Medicine Market Share Forecast by Country, 2023 & 2033 (%)
Figure 26 Europe Regenerative Medicine Market Forecast by Product, 2023-2033 (US$ billion)
Figure 27 Europe Regenerative Medicine Market Share Forecast by Product, 2023 & 2033 (%)
Figure 28 Europe Regenerative Medicine Market Forecast by Application, 2023-2033 (US$ billion)
Figure 29 Europe Regenerative Medicine Market Share Forecast by Application, 2023 & 2033 (%)
Figure 30 Germany Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 31 France Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 32 UK Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 33 Italy Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 34 Spain Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 35 Russia Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 36 Rest of Europe Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 37 Asia Pacific Regenerative Medicine Market Attractiveness Index
Figure 38 Asia Pacific Regenerative Medicine Market by Region, 2023, 2028 & 2033 (US$ billion)
Figure 39 Asia Pacific Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 40 Asia Pacific Regenerative Medicine Market Share Forecast by Country, 2023 & 2033 (%)
Figure 41 Asia Pacific Regenerative Medicine Market Forecast by Product, 2023-2033 (US$ billion)
Figure 42 Asia Pacific Regenerative Medicine Market Share Forecast by Product, 2023 & 2033 (%)
Figure 43 Asia Pacific Regenerative Medicine Market Forecast by Application, 2023-2033 (US$ billion)
Figure 44 Asia Pacific Regenerative Medicine Market Share Forecast by Application, 2023 & 2033 (%)
Figure 45 Japan Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 46 China Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 47 India Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 48 Australia Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 49 South Korea Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 50 Rest of Asia Pacific Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 51 Latin America Regenerative Medicine Market Attractiveness Index
Figure 52 Latin America Regenerative Medicine Market by Country, 2023, 2028 & 2033 (US$ billion)
Figure 53 Latin America Regenerative Medicine Market Forecast by Country, 2023-2033 (US$ billion)
Figure 54 Latin America Regenerative Medicine Market Share Forecast by Country, 2023 & 2033 (%)
Figure 55 Latin America Regenerative Medicine Market Forecast by Product, 2023-2033 (US$ billion)
Figure 56 Latin America Regenerative Medicine Market Share Forecast by Product, 2023 & 2033 (%)
Figure 57 Latin America Regenerative Medicine Market Forecast by Application, 2023-2033 (US$ billion)
Figure 58 Latin America Regenerative Medicine Market Share Forecast by Application, 2023 & 2033 (%)
Figure 59 Brazil Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 60 Mexico Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 61 Rest of Latin America Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 62 MEA Regenerative Medicine Market Attractiveness Index
Figure 63 MEA Regenerative Medicine Market by Country, 2023, 2028 & 2033 (US$ billion)
Figure 64 MEA Regenerative Medicine Market Forecast by Country, 2023-2033 (US$ billion)
Figure 65 MEA Regenerative Medicine Market Share Forecast by Country, 2023 & 2033 (%)
Figure 66 MEA Regenerative Medicine Market Forecast by Product, 2023-2033 (US$ billion)
Figure 67 MEA Regenerative Medicine Market Share Forecast by Product, 2023 & 2033 (%)
Figure 68 MEA Regenerative Medicine Market Forecast by Application, 2023-2033 (US$ billion)
Figure 69 MEA Regenerative Medicine Market Share Forecast by Application, 2023 & 2033 (%)
Figure 70 GCC Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 71 South Africa Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 72 Rest of MEA Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 73 Company Share Analysis, 2021
Figure 74 Amgen; Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 75 Amgen; R&D, 2017-2021 (US$ million, AGR %)
Figure 76 Amgen: Regional Market Shares, 2021
Figure 77 Anterogen; Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 78 Anterogen; R&D, 2017-2021 (US$ million, AGR %)
Figure 79 Avita Medical Inc.: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 80 Avita Medical, Inc.: R&D, 2017-2021 (US$ million, AGR %)
Figure 81 Avita Medical , Inc.: Regional Market Shares, 2021
Figure 82 Bio Solution Co. Ltd: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 83 Bluebird Bio, Inc.: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 84 Bluebird Bio, Inc.: R&D, 2017-2021 (US$ million, AGR %)
Figure 85 Bristol Myers Squibb: Net Revenue, 2017-2022 (US$ million, AGR%)
Figure 86 Bristol Myers Squibb; R&D, 2017-2022 (US$ million, AGR %)
Figure 87 Bristol Myers Squibb: Regional Market Shares, 2022
Figure 88 Gilead Sciences, Inc.: Net Revenue, 2017-2022 (US$ million, AGR%)
Figure 89 Gilead Sciences, Inc.: R&D, 2017-2022 (US$ million, AGR %)
Figure 90 Gilead Sciences, Inc.: Regional Market Shares, 2022
Figure 91 Integra LifeSciences.: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 92 Integra LifeSciences.: R&D, 2017-2021 (US$ million, AGR %)
Figure 93 Integra LifeSciences: Regional Market Shares, 2021
Figure 94 Mesoblast Ltd.: Net Revenue, 2017-2022 (US$ million, AGR %)
Figure 95 Mesoblast Ltd.: R&D, 2017-2021 (US$ million, AGR %)
Figure 96 Novartis AG: Net Revenue, 2017-2022 (US$ million, AGR %)
Figure 97 Novartis AG: R&D, 2017-2022 (US$ million, AGR %)
Figure 98 Novartis AG:: Regional Market Shares, 2022
Figure 99 Organogenesis Inc.: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 100 Organogenesis Inc.: R&D, 2017-2021 (US$ million, AGR %)
Figure 101 Sarepta Therapeutics, Inc..: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 102 Sarepta Therapeutics, Inc.: R&D, 2017-2021 (US$ million, AGR %)
Figure 103 Smith & Nephew: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 104 Smith & Nephew:; R&D, 2017-2021 (US$ million, AGR%)
Figure 105 Smith & Nephew:: Regional Market Shares, 2021
Figure 106 Terumo BCT: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 107 Terumo BCT: R&D, 2017-2021 (US$ million, AGR %)
Figure 108 Terumo BCT:: Regional Market Shares, 2021